Dynamics in Post-pandemic Global Biosimilar Industry: Supply and Demand, Markets and Prices 2021-2027

Dynamics in Post-pandemic Global Biosimilar Industry: Supply and Demand, Markets and Prices 2021-2027

Report Code: KNJ647430 | No. of Pages: 160 | Category: Pharmaceuticals and Healthcare
Publisher: GRD Survey | Date of Publish: Mar-2021
Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Biosimilar market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Biosimilar market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

Segmented by Category
Human Growth Hormones

Monoclonal Antibodies

Insulin

Peptides

Erythropoietin

Others

Segmented by End User/Segment
Oncology

Chronic and Autoimmune Diseases

Growth Hormone Deficiency

Infectious Diseases

Others

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Pfizer

Novartis

Intas Pharmaceuticals Limited

Genor BioPharma

Dr. Reddy’s Laboratories

Coherus BioSciences

Celltrion

Boehringer Ingelheim

BioXpress Therapeutics

Biocon

BIOCAD

Allergan plc



Table of Contents

1 Product Introduction and Overview
    1.1 Product Definition
    1.2 Product Specification
    1.3 Global Market Overview
        1.3.1 Global Biosimilar Market Status and Forecast (2016-2027)
        1.3.2 Global Biosimilar Sales Value CAGR by Region
    1.4 Market Drivers, Inhibitors
        1.4.1 Market Drivers
        1.4.2 Market Inhibitors
        1.4.3 COVID-19 Impact Analysis
2 Global Biosimilar Supply by Company
    2.1 Global Biosimilar Sales Volume by Company
    2.2 Global Biosimilar Sales Value by Company
    2.3 Global Biosimilar Price by Company
    2.4 Biosimilar Production Location and Sales Area of Main Manufacturers
    2.5 Trend of Concentration Rate
3 Global and Regional Biosimilar Market Status by Category
    3.1 Biosimilar Category Introduction
        3.1.1 Human Growth Hormones

        3.1.2 Monoclonal Antibodies

        3.1.3 Insulin

        3.1.4 Peptides

        3.1.5 Erythropoietin

        3.1.6 Others
    3.2 Global Biosimilar Market by Category
        3.2.1 Global Biosimilar Sales Volume by Category (2016-2021)
        3.2.2 Global Biosimilar Sales Value by Category (2016-2021)
        3.2.3 Global Biosimilar Price by Category (2016-2021)
    3.3 North America: by Category
    3.4 Europe: by Category
    3.5 Asia Pacific: by Category
    3.6 Central & South America: by Category
    3.7 Middle East & Africa: by Category
4 Global and Regional Biosimilar Market Status by End User/Segment
    4.1 Biosimilar Segment by End User/Segment
        4.1.1 Oncology

        4.1.2 Chronic and Autoimmune Diseases

        4.1.3 Growth Hormone Deficiency

        4.1.4 Infectious Diseases

        4.1.5 Others
    4.2 Global Biosimilar Market by End User/Segment
        4.2.1 Global Biosimilar Sales Volume by End User/Segment (2016-2021)
        4.2.2 Global Biosimilar Sales Value by End User/Segment (2016-2021)
        4.2.3 Global Biosimilar Price by End User/Segment (2016-2021)
    4.3 North America: by End User/Segment
    4.4 Europe: by End User/Segment
    4.5 Asia Pacific: by End User/Segment
    4.6 Central & South America: by End User/Segment
    4.7 Middle East & Africa: by End User/Segment
5 Global Biosimilar Market Status by Region
    5.1 Global Biosimilar Market by Region
        5.1.1 Global Biosimilar Sales Volume by Region
        5.1.2 Global Biosimilar Sales Value by Region
    5.2 North America Biosimilar Market Status
    5.3 Europe Biosimilar Market Status
    5.4 Asia Pacific Biosimilar Market Status
    5.5 Central & South America Biosimilar Market Status
    5.6 Middle East & Africa Biosimilar Market Status
6 North America Biosimilar Market Status
    6.1 North America Biosimilar Market by Country
        6.1.1 North America Biosimilar Sales Volume by Country (2016-2021)
        6.1.2 North America Biosimilar Sales Value by Country (2016-2021)
    6.2 United States
    6.3 Canada
    6.4 Mexico
7 Europe Biosimilar Market Status
    7.1 Europe Biosimilar Market by Country
        7.1.1 Europe Biosimilar Sales Volume by Country (2016-2021)
        7.1.2 Europe Biosimilar Sales Value by Country (2016-2021)
    7.2 Germany
    7.3 France
    7.4 UK
    7.5 Italy
    7.6 Russia
    7.7 Spain
8 Asia Pacific Biosimilar Market Status
   8.1 Asia Pacific Biosimilar Market by Country
        8.1.1 Asia Pacific Biosimilar Sales Volume by Country (2016-2021)
        8.1.2 Asia Pacific Biosimilar Sales Value by Country (2016-2021)
    8.2 China
    8.3 Japan
    8.4 Korea
    8.5 Southeast Asia
    8.6 India
    8.7 Australasia
9 Central & South America Biosimilar Market Status
    9.1 Central & South America Biosimilar Market by Country
        9.1.1 Central & South America Biosimilar Sales Volume by Country (2016-2021)
        9.1.2 Central & South America Biosimilar Sales Value by Country (2016-2021)
    9.2 Brazil
    9.3 Argentina
    9.4 Colombia
10 Middle East & Africa Biosimilar Market Status
    10.1 Middle East & Africa Biosimilar Market by Country
        10.1.1 Middle East & Africa Biosimilar Sales Volume by Country (2016-2021)
        10.1.2 Middle East & Africa Biosimilar Sales Value by Country (2016-2021)
    10.2 Iran
    10.3 Israel
    10.4 Turkey
    10.5 South Africa
    10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
    11.1 Supply Chain Analysis
    11.2 Production Process Chart Analysis
    11.3 Raw Materials and Key Suppliers Analysis
        11.3.1 Raw Materials Introduction
        11.3.2 Raw Materials Key Suppliers List
    11.4 Biosimilar Manufacturing Cost Analysis
    11.5 Biosimilar Sales Channel and Distributors Analysis
        11.5.1 Biosimilar Sales Channel
        11.5.2 Biosimilar Distributors
    11.6 Biosimilar Downstream Major Buyers
12 Global Biosimilar Market Forecast by Category and by End User/Segment
    12.1 Global Biosimilar Sales Volume and Sales Value Forecast (2022-2027)
    12.2 Global Biosimilar Forecast by Category
        12.2.1 Global Biosimilar Sales Volume Forecast by Category
        12.2.2 Global Biosimilar Sales Value Forecast by Category
        12.2.3 Global Biosimilar Price Forecast by Category
    12.3 Global Biosimilar Forecast by End User/Segment
        12.3.1 Global Biosimilar Sales Volume Forecast by End User/Segment
        12.3.2 Global Biosimilar Sales Value Forecast by End User/Segment
        12.3.3 Global Biosimilar Price Forecast by End User/Segment
13 Global Biosimilar Market Forecast by Region/Country
    13.1 Global Biosimilar Market Forecast by Region (2022-2027)
        13.1.1 Global Biosimilar Sales Volume Forecast by Region (2022-2027)
        13.1.2 Global Biosimilar Sales Value Forecast by Region (2022-2027)
    13.2 North America Market Forecast
    13.3 Europe Market Forecast
    13.4 Asia Pacific Market Forecast
    13.5 Central & South America Market Forecast
    13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
    14.1 Pfizer

        14.1.1 Company Information
        14.1.2 Biosimilar Product Introduction
        14.1.3 Pfizer
 Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.1.4 SWOT Analysis
    14.2 Novartis

        14.2.1 Company Information
        14.2.2 Biosimilar Product Introduction
        14.2.3 Novartis
 Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.2.4 SWOT Analysis
    14.3 Intas Pharmaceuticals Limited

        14.3.1 Company Information
        14.3.2 Biosimilar Product Introduction
        14.3.3 Intas Pharmaceuticals Limited
 Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.3.4 SWOT Analysis
    14.4 Genor BioPharma

        14.4.1 Company Information
        14.4.2 Biosimilar Product Introduction
        14.4.3 Genor BioPharma
 Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.4.4 SWOT Analysis
    14.5 Dr. Reddy’s Laboratories

        14.5.1 Company Information
        14.5.2 Biosimilar Product Introduction
        14.5.3 Dr. Reddy’s Laboratories
 Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.5.4 SWOT Analysis
    14.6 Coherus BioSciences

        14.6.1 Company Information
        14.6.2 Biosimilar Product Introduction
        14.6.3 Coherus BioSciences
 Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.6.4 SWOT Analysis
    14.7 Celltrion

        14.7.1 Company Information
        14.7.2 Biosimilar Product Introduction
        14.7.3 Celltrion
 Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.7.4 SWOT Analysis
    14.8 Boehringer Ingelheim

        14.8.1 Company Information
        14.8.2 Biosimilar Product Introduction
        14.8.3 Boehringer Ingelheim
 Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.8.4 SWOT Analysis
    14.9 BioXpress Therapeutics

        14.9.1 Company Information
        14.9.2 Biosimilar Product Introduction
        14.9.3 BioXpress Therapeutics
 Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.9.4 SWOT Analysis
    14.10 Biocon

        14.10.1 Company Information
        14.10.2 Biosimilar Product Introduction
        14.10.3 Biocon
 Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.10.4 SWOT Analysis
    14.11 BIOCAD

    14.12 Allergan plc

15 Conclusion
16 Methodology


List of Tables and Figures
Ask Sample Report to get more details…

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com